Voloridge Investment Management
QTTB icon

Voloridge Investment Management’s Q32 Bio QTTB Stock Holding History

Voloridge Investment Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-931
Closed -$347K – 1452
2019
Q4 		$347K Buy
+931
New +$267K 0.01% 895

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Voloridge Investment Management's QTTB Position: Q1 2020 in Review

Voloridge Investment Management sold out of Q32 Bio (QTTB) in Q1 2020, closing a stake of 931 shares — an estimated $347K sold.

Voloridge Investment Management first reported a position in QTTB in Q4 2019 and held it in 1 quarter. The position peaked at $347K in Q4 2019. 91 funds tracked by Wall St. Rank hold QTTB as of Q1 2020.

  • Voloridge Investment Management reported no remaining Q32 Bio position as of Q1 2020 after selling out during the quarter.
  • Voloridge Investment Management sold 931 Q32 Bio shares in Q1 2020, an estimated $347K.
  • Voloridge Investment Management first reported a position in Q32 Bio in Q4 2019 and held it in 1 quarter.
  • Voloridge Investment Management's Q32 Bio position peaked at $347K in Q4 2019.
  • 91 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2020.

Based on Voloridge Investment Management's 13F filing for Q1 2020, filed 15 May 2020.